The mammary gland is composed of basal cells and luminal cells. It is generally believed that the mammary gland arises from embryonic multipotent progenitors, but it remains unclear when lineage restriction occurs and what mechanisms are responsible for the switch from multipotency to unipotency during its morphogenesis. Here, we perform multicolour lineage tracing and assess the fate of single progenitors, and demonstrate the existence of a developmental switch from multipotency to unipotency during embryonic mammary gland development.
T he mammary gland (MG) is a branched epithelium that produces milk during lactation. It is composed of two main lineages: basal cells (BCs), surrounding inner luminal cells (LCs). The LCs can be subdivided into oestrogen receptor (esr1 or ER)-positive and negative ductal cells, and alveolar cells that produce milk 1 .
The MG derives from the ectoderm at around embryonic day 10.5 (E10.5). At E13, the MG placodes invaginate to form buds that continue to sprout until E16, when they start to branch. By E18.5, the epithelium forms a rudimentary ductal structure. From E18.5, the MG grows proportionally to the body size until puberty when oestrogen stimulates rapid growth and further branching of the MG. During pregnancy and lactation, MG further develops and gives rise to alveolar LCs that differentiate into milk-producing cells. At the end of lactation, the MG involutes and goes back to its virgin appearance, ready to undergo a new cycle of growth in the next pregnancy 1 .
Lineage tracing experiments demonstrate that postnatal pubertal development and adult remodelling are mediated by unipotent basal and luminal progenitors/stem cells [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Whereas multicolour clonal analysis combined with statistical modelling demonstrates the unipotency of adult BCs and LCs [10] [11] [12] , such experimental approaches have never been undertaken during MG development. Lineage tracing of the keratin 14 (K14)-expressing cells that compose the embryonic MG at E17 demonstrated that both basal and luminal lineages arise from K14-expressing cells during embryonic development 8 , and suggest the existence of embryonic multipotent progenitors (EMPs). However, these experiments cannot discriminate whether the apparent multipotency of embryonic MG arises from the labelling of distinct pools of already pre-committed BCs and LCs or whether EMPs are truly multipotent at the single cell level. In addition, it remains unclear when the basal and luminal lineage segregation occurs and what are the mechanisms responsible for the switch from multipotency to unipotency during MG morphogenesis.
Here, using multicolour clonal analysis in mice, we demonstrate the multipotency of EMPs and the existence of a switch from multipotency to unipotency that occurs during embryonic MG development. Using molecular profiling and single cell RNA sequencing, we demonstrate that multipotency is associated with a hybrid basal and luminal gene expression signature. Finally we show the key role of p63 in promoting BC fate in EMPs.
Results
Clonal analysis demonstrates the switch from multipotency to unipotency during MG development. To assess whether MG arises from early multipotent progenitors or from a mixture of different lineage restricted progenitors, we performed clonal analysis using lineage tracing experiments at the early stages of MG development, when K14 is homogenously expressed in all MG cells (Fig. 1a ). To this end, we generated K14rtTA/TetO-Cre/Rosa-Confetti mice ( Fig. 1b ) and titrated the dose of doxycycline (DOX) that leads to clonal labelling of the MG. Among the four colours of the confetti reporter system, nGFP is much less frequently recombined than the other fluorescent proteins 10, 13, 14 . Consequently, nuclear GFP (nGFP) can be used to further ensure clonal labelling in lineage tracing experiments. By administrating 1 µ g of DOX per g of mouse to pregnant mice at E13 by intravenous injection (i.v.), we found that about 80% of the MGs were not labelled by nGFP ( Fig. 1c,d) . Similar proportions of MGs (20%) were labelled with nGFP two days after the injection (E15) and at postnatal day 5 (P5) when MG has branched and basal and luminal lineages are clearly separated ( Fig. 1d-f ).
Hybrid adult basal and luminal gene expression in EMPs.
To understand the molecular mechanisms regulating embryonic multipotency, we developed a strategy to FACS (fluorescence-activated cell sorting) isolate EMPs at E14, enabling us to compare their transcriptome to adult BCs and LCs. To this end, we used Lgr5-GFP Lgr5-GFP   50 100 150 200 250   10   2   10   3   10   4   10   5   50 100 150 200 250   10   2   10   3   10   4   10   5 In 
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reporter mice 15 to specifically isolate EMPs (CD49f Hi /Lgr5-GFP Hi ) from the underlying mesenchyme and surrounding epidermis 16 and compared their transcriptome to adult BCs (CD24 + CD29 Hi ) and LCs (CD24+ CD29 Lo ) 17 ( Fig. 2a-d and Supplementary Fig. 1 ).
To determine to what extent EMPs resemble adult BCs, we compared the transcriptome of EMPs with LCs and defined the genes upregulated 1.5-fold in EMPs (embryonic basal signature) and assessed which genes upregulated in this signature were also upregulated in adult BCs (when compared to LCs) by more than 1.5-fold (adult basal signature). A high proportion of the genes of the adult basal signature were also upregulated in EMPs when compared to LCs (22.3%) ( Fig. 2e ). Lgr5-isolated EMPs expressed a number of genes previously shown to be enriched in laser capture embryonic MG 18 . Gene set enrichment analysis (GSEA) confirmed the high enrichment of adult basal genes in EMPs (Fig. 2f ). Interestingly, when
EMPs were compared with adult BCs (embryonic luminal signature) and assessed for the expression of markers of the adult luminal signature (genes upregulated 1.5-fold in adult LCs when compared to BCs), EMPs also expressed luminal-specific genes ( Fig. 2g ). GSEA confirmed the enrichment of adult luminal genes in EMPs (Fig. 2h ). These data demonstrate that, at the population level at E14, EMPs express genes of basal and luminal lineages. Gene ontology (GO) analysis of the genes belonging to the basal signature and expressed in EMPs revealed a high enrichment for developmental proteins Wnt, Edar Pth, TGFβ , and Notch pathways ( Fig. 2i,j and Supplementary Fig. 2a ), which are well known to regulate MG morphogenesis and adult maintenance 3, 5, [19] [20] [21] [22] [23] [24] [25] [26] [27] . Extracellular matrix (ECM) genes were also strongly enriched ( Fig. 2i,k and Supplementary Fig. 2a ), suggesting that these progenitors contribute to the formation of their own niche. In addition, . g-j, Scatter plots depicting the linear relationship in the EMP population (n = 68) between regulon activity and the adjusted proportion of specific LC (g,i) and BC (h,j) markers for Trp63 (g,h) and Sp1 (i,j) regulons. Regulon activity was measured as the regulon AUC, which is a function of the number of inferred target genes of that regulon being expressed (0 means no genes and 1 means all genes being expressed). The red line represents a linear model fitted using the lm function in R, and the grey area represents the 95% confidence interval.
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EMPs were enriched in developmental proteins, including Trp63, a key transcription factor (TF) known to be essential for MG embryonic development and expressed in adult BCs [28] [29] [30] , and epithelial to mesenchymal transition (EMT) genes ( Fig. 2l ), a feature associated with embryonic MG 31 and adult BCs 32 . EMPs also expressed cell adhesion and cytoskeleton molecules including basal keratins, members of the planar cell polarity pathway, growth factor binding and axon guidance molecules (Fig. 2i,k and Supplementary  Fig. 2a,b ), which may regulate the growth and branching of MG.
Oncogenic Pik3ca expression in adult BCs or LCs promotes the activation of a multipotent program 17 . Interestingly, the EMP basal signature encompassed a high number of genes (31.2%, 124 out of 398 genes) previously associated with the oncogenic Pik3cainduced multipotency signature ( Fig. 2m -o) 17 . GO analysis of the genes of the adult luminal signature expressed in the EMPs revealed that the EMPs were highly enriched for genes regulating cell cycle and mitosis ( Supplementary Fig. 2c-e ), and for well-known key regulators promoting MG luminal lineage 
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NATuRe Cell BIology specification and maintenance 18, [33] [34] [35] [36] [37] [38] , together with the known ER+ and ER− luminal markers ( Fig. 2n ) that characterize luminal lineages 9, 39 . A significant proportion of the EMP luminal signature was common with the oncogenic Pik3ca-induced multipotent gene signature (14.3%, 20 out of 140 genes) ( Fig. 2o ).
Single cell RNA-seq uncovers the hybrid EMP signature. To further define the molecular features associated with the multipotency of EMPs at the early stages of MG morphogenesis, we performed single-cell RNA-seq (scRNA-seq) following a SMARTseq2-based approach on FACS-isolated cells. After very stringent quality control, 69 single EMPs at E14, 51 adult BCs and 73 adult LCs were retained for downstream analyses. Unsupervised clustering analysis using the SC3 method 40 showed that these cells could be individualized into four main clusters specific for the EMPs, adult BCs and both Esr1+ and Esr1− LCs ( Fig. 3a and Supplementary Fig. 3 ). EMPs were specifically enriched for genes that regulate proliferation and signalling and were previously reported to be expressed in breast cancers [41] [42] [43] [44] [45] [46] [47] , whereas BCs and LCs expressed classical basal and luminal genes, respectively. GO analysis of the single-cell signature of EMPs, similar to the microarray analysis, showed high enrichment for developmental proteins, differentiation, transcription, axon guidance, Wnt signalling and ECM genes ( Supplementary  Fig. 3 ). EMPs at E14 did not express Sox10, contrasting with its expression in late embryonic development (E18.5) and adult MG 31, 38 ( Supplementary Fig. 3d ). The four main clusters found by SC3 were also found by dimensionality reduction using t-distributed stochastic neighbour embedding (t-SNE) and principal component analysis (PCA) (Fig. 3b,c We then assessed whether EMPs constitute a transcriptionally homogenous population expressing a hybrid LC/BC gene signature or are composed of distinct pre-committed subpopulations of cells with distinct gene signatures corresponding to BC or LC progenitors. Only scRNA-seq can discriminate between these two scenarios. We performed SC3 unsupervised clustering on the EMPs only, and found two subclusters ( Fig. 3d ). One subcluster comprises the majority of EMPs, expressing no significant cluster-specific marker genes. The second subcluster represents a proliferative subpopulation of EMPs expressing marker genes associated with cell cycle. To avoid aberrant clustering, these cycling cells were omitted from further analysis. Very interestingly, only EMPs, and not adult LCs or BCs, expressed a hybrid transcriptional signature comprising markers for both LC and BC lineages ( Fig. 3e and Supplementary Fig. 4 ). Lowering the stringency of the quality controls for the scRNA-seq pipeline, such as the number of expressed genes per cell, may result in the appearance of a few adult LCs and BCs with artefactual hybrid gene expression profiles ( Supplementary Fig. 5 ).
We also found that a few Lgr5-expressing cells at E14 were clustered in a separate mesenchymal cluster distinct from all the other EMPs. Some of these cells did not express any epithelial markers, including K14, K5 or K8, and correspond to stromal cells of the embryonic MG, which were not eliminated by the α 6-integrin/ CD49f FACS gating strategy that separates embryonic mammary epithelial from mesenchymal Lgr5-expressing cells. However, a few epithelial cells, as demonstrated by their keratin expression, also expressed a higher level of mesenchymal genes, and thus correspond to an EMT hybrid state ( Supplementary Fig. 6a ).
By looking at the proportion of exclusively expressed lineagespecific markers in EMPs, we observed no clear subpopulations of EMPs expressing a higher proportion of either sets of genes ( Fig. 3e and Supplementary Fig. 6 ), suggesting that EMPs were not committed to the basal or luminal lineage at E14.
To further assess the regulatory mechanisms associated with the different cell states, we performed gene regulatory network analysis using SCENIC 48 , which allows the identification of regulatory modules by inferring co-expression between TFs and genes containing the respective TF binding motif in their regulatory regions. 
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These modules or regulons were then assessed in each cell to ascertain their activity and infer cell-specific states. By hierarchical clustering of the cells according to the binary activity of regulons, we recapitulated the clusters previously found by SC3. We identified regulons active only in EMPs, only in LCs, only in BCs, in both EMPs and LCs, and in EMPs and BCs (Fig. 4a-f ). We then investigated the correlation between the degree of regulon activity by the number of their expressed target genes, and basal or luminal marker expression. Interestingly, in the EMP population we identified TFs such as p63 for BC or Sp1 for LC, which showed opposite correlations to LC and BC marker expression, suggesting their role as cell lineage regulators ( Fig. 4g-j) .
Asymmetrical expression of basal and luminal markers marks the early step of lineage segregation.
To gain further insight into the mechanisms that regulate cellular heterogeneity and lineage segregation during MG morphogenesis, we assessed by immunofluorescence the temporal expression of basal and luminal markers differentially regulated at the bulk mRNA level in EMPs, adult BCs and LCs. At E14, basal (K14 and p63) and luminal (K8 and Sox9) markers were expressed in all cells of the MG, although lower levels of K8 were already visible along the outer region of the embryonic MG ( Fig. 5a-e ). At E17, the cells of the outer layer of the embryonic MG expressed p63 and lower levels of K8, whereas the inner cells of the embryonic MG expressed higher levels of K8 and no p63 ( Fig. 5a,d) . Sox9, which is expressed by a fraction of adult LCs 9,10,49 was still expressed by BCs and LCs at this stage of embryonic development ( Fig. 5e ). Foxa1 and ER were only observed at the protein level in a fraction of LCs during late embryogenesis for Foxa1 and in the postnatal MG for ER ( Fig. 5f,g) . Basal markers SMA and smMHC (Fig. 5b,c) , which were detected at E14 at the mRNA level, were only detected at the protein level at P1 in outer BCs.
p63 promotes unipotent BC fate in EMPs. To further dissect the molecular mechanisms associated with MG lineage segregation, we assessed whether p63 controls the switch from multipotency to BC unipotency during MG development. p63 deletion during embryonic development leads to the absence of MG formation 28, 29 , demonstrating the essential early function of p63 during MG specification but preventing study of the role of p63 in MG lineage segregation. Overexpression or ShRNA knockdown of Δ Np63 in primary culture of mouse mammary epithelial cells (MMECs) in vitro showed that Δ Np63 decreases the expression of LC markers and increases BC marker expression, suggesting that Δ Np63, directly or indirectly, regulates BC characteristics. Furthermore, transplantation of MMECs overexpressing Δ Np63 reduced the proportion of LCs in the MG outgrowth, suggesting that downregulation of Δ Np63 is required for proper luminal lineage differentiation 50 . However, it remains unclear whether the spatial restriction of Δ Np63 expression during MG embryonic development is important to promote BC fate.
To address this question, we used a genetic approach allowing p63 expression to be sustained in the outer and inner cells of the embryonic MG 51 . DOX administration to K14rtTA/TetO-Cre/ Rosa-tdTomato at E13 led to labelling of the same proportion of BCs (Tomato+ /K14+ ) and LCs (Tomato+ /K8+ ) (70%) at P5. In contrast, DOX administration to K14rtTA/TetO-Cre/Rosa-Δ Np63-IRES-GFP mice led to the labelling of 70% of BCs (GFP+ /K14+ ) and only 10% of LCs (Fig. 6a-h) , demonstrating that most LCs arise from the rare EMPs that did not express the p63 transgene.
Reprogramming of adult LCs into BCs by
ΔNp63. We next examined whether Δ Np63 could reprogram adult LCs into the BC lineage, and if so by which molecular mechanisms. To express Δ Np63 in adult LCs, we administered DOX for seven consecutive days to four-week-old K8rtTA/TetO-Cre/Rosa-Δ Np63-IRES-GFP females ( Fig. 7a,b) , and analysed the presence of GFP in BCs and LCs by FACS two weeks after the last DOX administration. Interestingly, we found that Δ Np63 expression in adult LCs was sufficient to reprogram a fraction of Δ Np63 expressing LCs into BCs (Fig. 7c ), demonstrating the important plasticity of LCs and the master regulatory function of Δ Np63 to promote BC fate in vivo.
To gain further insights into the cellular mechanisms that accompanied LC fate transition upon ectopic p63 expression, we performed immunofluorescence characterization of the MG during the cellular reprogramming. In good accordance with the FACS data, p63 immunostaining showed that p63 was expressed in about half of the LCs (Fig. 7d) . Interestingly, we found that some LCs expressing p63-IRES-GFP co-expressed basal and luminal markers ( Fig. 7e-g and Supplementary Fig 7) . Most of these hybrid cells were still located in the inner cells together with the other LCs, and still presented the round shape of LCs ( Fig. 7e-g) . More rarely at this stage, some of these p63-targeted LCs were located in the outer part of the mammary epithelium, lost the expression of LC markers, expressed BC markers and presented BC elongated morphology (Fig. 7f) . Although p63-IRES-GFP was initially evenly expressed in ER/PR+ and − LCs, the LCs that co-expressed basal and luminal markers did not express Foxa1 or PR ( Fig. 7g and Supplementary  Fig. 7d ), suggesting that LCs need to shut down their hormone receptor differentiation program to undergo cell fate reprogramming upon Δ Np63 expression.
To understand the molecular mechanisms by which Δ Np63 reprograms adult LCs into BCs, we performed bulk RNA-seq of FACS-isolated LCs and BCs upon Δ Np63 expression in adult MGs. Gene clustering demonstrated that the newly generated basal-like cells upon Δ Np63 expression in LCs molecularly resemble WT BCs (Fig. 7h) . Venn diagrams and GSEA also showed that a very significant fraction of the LC upregulated genes upon Δ Np63 expression belong to the BC signature and, among the 48 p63 target genes inferred by SCENIC, 18 were overexpressed in LCs expressing Δ Np63 (P = 1.349e-06 given a random sampling of genes; Fig. 7i and Supplementary Fig. 7) , supporting the notion that Δ Np63 expression in LCs induced a transient hybrid multipotent state before the de novo generation of BCs. GO analysis showed that the genes upregulated by Δ Np63 in LCs are highly enriched for cytoskeleton, cilium biogenesis and cell division genes (Fig. 7j) . Interestingly, the scRNA-seq EMP signature was also enriched in adult LCs expressing Δ Np63 (Fig. 7k) . A subset of the most upregulated genes in adult LCs expressing Δ Np63 versus WT LCs were expressed in the single-cell EMP data but not in BCs, further suggesting that the reprogramming of adult LCs following Δ Np63 expression leads to a multipotent embryonic-like hybrid state before giving rise to fully reprogrammed BCs (Fig. 7l ).
Discussion
Here, using clonal analysis during MG development, we formally demonstrate that MG initially develops from EMPs that rapidly switch from multipotency to unipotency during the course of embryonic development. Similar conclusions were made from lineage tracing experiments using Notch1-CreER at different stages of embryogenesis in a related study in ref. 52 . This rapid switch from multipotency to unipotency may explain the very rare and large bipotent clones dispersed from the nipple region to the distal part of the epithelial tree found in lineage tracing induced by random recombination 12 .
Microarray and scRNA-seq analyses indicate that EMPs are associated with a hybrid signature that overlaps with both basal and luminal lineages. The greater resemblance of EMPs to BCs may explain why BCs are multipotent in transplantation assays 4, 7, 8 . The hybrid gene expression of EMPs at E14 sharing similarities with both BCs and LCs is consistent with their multipotent fate at this stage of embryonic development.
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Reactivation of multipotency is associated with the early stages of mammary tumour initiation and the development of tumour heterogeneity. Our data showing that EMPs express the same genes as expressed during the reactivation of multipotency and cell fate changes induced by oncogenic Pik3ca expression 17 support the notion that the mechanisms associated with multipotency during tumorigenesis recapitulate at least partially the genetic program that regulates multipotency during embryonic MG development. Moreover, many genes found to be specifically expressed in EMPs by scRNA-seq such as Sox11, Stmn1 and Mdk are expressed in human breast cancers with poor prognosis [41] [42] [43] [44] [45] [46] , further suggesting that the reactivation of an EMP gene expression program during tumorigenesis is essential for tumour growth and invasion.
Temporal in situ characterization reveals that the early signs of lineage segregation visible at the protein level consist of a restricted expression of p63 together with a decreased expression of K8 in the outermost layer of the embryonic MG in contact with the stroma. By sustaining the expression of p63 in EMPs, we found that p63 promotes the differentiation of EMPs into BCs during MG development. Similarly, p63 overexpression in adult MMECs decreases the formation of LCs upon transplantation of these cells into the mammary mesenchyme 50 . Expression of p63 in adult LCs is sufficient to reprogram these cells into BCs, further demonstrating that p63 acts as a master regulator of BC fate. It has been proposed that p63 and Notch signalling act in an opposite manner to promote, respectively, BC and LC fates 50, 52 . It is thus possible that the downregulation of K8 and the restricted expression of p63 at the outer layer are the consequences of an inhibition of Notch signalling in these cells.
Ectopic expression of Δ Np63 in adult LCs induces the reprogramming of these cells into basal-like cells. This cell fate change is a progressive process rather than a direct trans-differentiation event that passes through a hybrid state, reminiscent of the EMP. Our molecular analysis identifies a specific gene program regulated by p63 sufficient to convert an adult LC into a BC and that encompasses many genes expressed by EMPs, further suggesting that the cell fate reprogramming of an LC into a BC by p63 reactivates some features of the embryonic multipotent genetic program.
Although our study uncovers the importance of hybrid gene expression in regulating the multipotent state during embryonic development and p63-mediated reprogramming of adult LCs into BCs, and defines the BC molecular program controlled by p63 under these conditions, many important questions remain unanswered. Further studies will be needed to better understand the molecular mechanisms that regulate the switch from multipotency to unipotency during MG development. What are the intrinsic and extrinsic signals that act upstream and sustain the expression of p63 and inhibit the expression of luminal genes in the inner part of the MG at the early stage of lineage segregation? What are the key p63 target genes that regulate BC fate in EMP and the reactivation of multipotency in adult unipotent luminal SCs? What is the role of the genes other than p63 that are specifically expressed by EMPs and regulate multipotency during development? As p63 is also expressed in the basal lineage of other epithelial tissues 53, 54 , the key role of p63 in regulating the switch from multipotency to unipotency is likely to be conserved across different organs. Defect in lineage segregation and regulation of multipotency by p63 may potentially explain some pathological features of the different developmental syndromes affecting these tissues, including the MG, that are associated with p63 mutations in humans 55 .
In conclusion, our study identifies the temporal switch from multipotency to unipotency that occurs during MG development, as well as the molecular mechanisms that regulate cell fate transition and lineage segregation during this process. The paradigm and molecular mechanisms uncovered here have important implications for understanding multipotency, unipotency and lineage segregation in other tissues and during tumorigenesis.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0095-2.
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Methods
Mice. Lgr5-EGFP-IRES-CreER 15 and Rosa-tdTomato 56 mice were obtained from the Jackson Laboratory. Rosa-Confetti 13 mice were provided by H. Clevers. K14rtTA transgenic mice 57 were provided by E. Fuchs. TetO-Cre mice 58 were provided by A. Nagy. Rosa26-Δ Np63-IRES-GFP mice 51 were provided by W. Declercq. The generation of K5CreER and K8rtTA has been described previously 8, 10 . Mice colonies were maintained in a certified animal facility in accordance with European guidelines. The experiments were approved by the local ethical committee (CEBEA) under protocols #477 and #527. The study is compliant with all relevant ethical regulations regarding animal research. Mice were analysed at embryonic stages E14, E15 and E17, during postnatal development at P1, P5, P21, P60 and 7w and in adult mice (over 8w), as indicated in the figure legends.
Targeting Confetti, tdTomato or ΔNp63-IRES-GFP expression in the MG. For clonal lineage tracing, K14rtTA/TetO-Cre/Rosa-Confetti embryos were induced at E13 by i.v. injection in the tail vein of pregnant mothers with 1 µ g doxycycline per g (diluted in sterile PBS, Sigma cat. no. D9891) and at E15 or P5. K5CreER/ Rosa-Confetti pups at P1 were induced by intraperitoneal (i.p.) injection of 50 µ g tamoxifen (diluted in sunflower seed oil, Sigma cat. no. T5648) and killed 21 days later. For K14rtTA/TetO-Cre/Rosa-tdTomato or K14rtTA/TetO-Cre/ Rosa-Δ Np63-IRES-GFP, embryos were induced at E13 by i.v. injection of pregnant mothers with 15 µ g doxycycline per g (diluted in sterile PBS) and killed at P5. K8rtTA/TetO-Cre/Rosa-Δ Np63-IRES-GFP female mice were induced at 4w with doxycyclin 10 g kg −1 in diet (Bio-Serv), 2 g l −1 in drinking water (AG Scientific cat. no. D2545) and three intraperitoneal injections of 2 mg in 200 µ l PBS over 7 days.
MG whole-mount (WM) processing and immunostaining.
For MG processing at E15, whole embryos were collected and fixed in PFA 4% for 2 h at room temperature (RT) or overnight at 4 °C. The following day, the whole skin (of female embryos) containing mammary buds was dissected and stained as detailed in the following. For MG processing at P5, thoracic and inguinal MGs were dissected and fixed in PFA 4% for 2 h at RT or overnight at 4 °C, then stained. For MG processing at P21, inguinal glands were dissected and enzymatically digested in HBSS (GIBCO) + 300 U ml −1 collagenase (Sigma cat. no. C0130) + 300 µ g ml −1 hyaluronidase (Sigma cat. no. 4272) for 20 min at 37 °C under shaking. Glands were fixed in PFA 4% for 2 h at RT. Confetti samples were washed in NH 4 Cl (0.5 M in PBS) for 20 min, followed by washes in PBS. For WM immunostaining, all samples were incubated in blocking buffer for 3 h (bovine serum albumin (BSA) 1%, horse serum (HS) 5%, TritonX 0,8% in PBS) at RT. The different primary antibodies were incubated overnight at RT and washed for 1 h at RT with PBS 0.2% Tween20 before incubation with secondary antibodies diluted in blocking buffer at 1:400 for 5 h at RT. The following primary antibodies were used: anti-K14 (rabbit or chicken, 1:1,000, Thermo), anti-K8 (rat, 1:500, Developmental Studies Hybridoma Bank, University of Iowa), anti-GFP (chicken, 1:500, ab13970, Abcam). The following secondary antibodies were used: anti-rabbit, anti-rat, anti-chicken conjugated to AlexaFluor488 (Molecular Probes), Rhodamine Red-X or Cy5 (JacksonImmunoResearch) . Nuclei were stained with a Hoechst solution (1:1,000 in PBS 0.2% Tween20) for 30 min and washed for another hour in PBS 0.2% Tween20 before mounting on slides in DAKO mounting medium supplemented with 2.5% Dabco (Sigma).
MG immunofluorescence on sections. Whole embryos and newborn pups collected at E13, E14 and E17 and dissected MGs from P5 and adult mice were pre-fixed in PFA 4% for 2 h at RT or directly embedded in optimum cutting temperature (OCT) compound (Sakura) and kept at − 80 °C. Pre-fixed tissues were washed in PBS, incubated overnight in 30% sucrose in PBS at 4 °C and embedded in OCT and kept at − 80 °C. Sections of 10 µ m were cut using a HM560 Microm cryostat (Mikron Instruments). Tissue sections were fixed in PFA 4% for 10 min at RT (for non-pre-fixed sections only) and incubated in blocking buffer (BSA 1%, HS 5%, Triton-X 0.2% in PBS) for 1 h at RT. The different primary antibodies were incubated overnight at 4 °C. Sections were then rinsed in PBS and incubated with the corresponding secondary antibodies diluted at 1:400 in blocking buffer for 1 h at RT. The following primary antibodies were used: anti-GFP (chicken, 1:1,000, ab13970, Abcam), anti-K8 (rat, 1:1,000, Troma-I, Developmental Studies Hybridoma Bank, University of Iowa), anti-K14 (rabbit or chicken, 1:1,000, Thermo), anti-K5 (rabbit, 1:1,000, PRB-160P-0100, Covance), anti-CD49f-PE (rat, 1:100, clone GoH3, eBiosciences), anti-p63 (rabbit, 1:500, clone EPR5701, Abcam), anti-SMA-Cy3 (mouse, 1:500, clone 1A4, Sigma), anti-smMHC (rabbit, 1:100, BT562, Biomedical Technologies), anti-Sox9 (rabbit, 1:5,000, AB5535, Millipore), anti-FoxA1 (rabbit, 1:100, clone EPR10881, Abcam), anti-ER (rabbit, 1:300, sc542, Santa Cruz), anti-PR (rabbit 1/250, MA5-14505, ThermoFisher Scientific) and anti-Ecadherin (rat, 1/500, 14-3249-82, Ebioscience). The following secondary antibodies, diluted 1:400, were used: anti-rabbit (A21206), anti-rat (A21208), anti-chicken (A11039) conjugated to AlexaFluor488 (Molecular Probes), anti-rabbit (711-295-152), anti-rat (712-295-153), anti-chicken (703-295-155) Rhodamine Red-X or anti-rabbit (711-605-152), anti-rat (712-605-153) and antichicken (703-605-155) Cy5 (JacksonImmunoResearch) . Nuclei were stained with Hoechst solution (1:2,000) and slides were mounted in DAKO mounting medium supplemented with 2.5% Dabco (Sigma).
Microscope image acquisition.
Confocal images were acquired at RT using a Zeiss LSM780 confocal microscope fitted on an Axiovert M200 inverted microscope equipped with a C-Apochromat (× 40, NA = 1.2) water immersion objective (Carl Zeiss). Optical sections (1,024 × 1,024 pixels) were collected sequentially for each fluorochrome. The data sets generated were merged and displayed with ZEN 2 software.
Quantification of percent GFP-labelled glands and clone composition. Whole mounts of E15 and P5 K14rtTA/TetO-Cre/Rosa-Confetti MG were analysed by confocal microscopy. For E15 embryos, 73 MGs (n = 8 embryos, 1 litter) were analysed, among which 11 were positive for the presence of nGFP cells (16%). For P5 mice, 85 MGs (n = 13 mice, 4 litters) were analysed, among which 22 were positive for the presence of nGFP cells (26%). At P5, clones were scored according to their keratin expression into basal (K14+ ), luminal (K8+ ) and bipotent clones (K14+ /K8+ ). Whole mounts of P21 K5CreER/Rosa-Confetti MG were analysed by confocal microscopy. At P21, 36 unipotent basal clones were analysed (from 12 MGs, n = 3 mice). See Supplementary Table 1 for further details.
Quantification of percent labelled cells.
Whole-mounts stained for K14, K8 and GFP were analysed by confocal microscopy. Then, 2,417, 2,234 and 2,249 total cells from three different mice were quantified in K14rtTA/TetO-Cre/Rosa-Δ Np63-IRES-GFP; and 2,428, 2,031, 2,315 and 2,601 cells from four different mice were analysed in K14rtTA/TetO-Cre/Rosa-tdTomato. The proportion of labelled LCs in K14rtTA/TetO-Cre/Rosa-tdTomato or K14rtTA/TetO-Cre/Rosa-Δ Np63-IRES-GFP was quantified as the ratio of K8+ Tomato+ or GFP+ LCs over total K8+ LCs, whereas the proportion of labelled BCs was quantified as the ratio of K14+ Tomato+ or GFP+ BCs over K14+ total BCs. Mammary cell preparation. E14 Lgr5-GFP embryos were collected and the whole skin containing the MGs was dissected. Tissues were digested in 300 U ml −1 collagenase (Sigma cat. no. C0130) + 300 µ g ml −1 hyaluronidase (Sigma cat. no. 4272) diluted in HBSS for 1 h 30 min at 37 °C under shaking. EDTA at a final concentration of 5 mM was added for 3 min, followed by two washes in 10% FBS/ PBS and 2% FBS/PBS before filtration through a 40 µ m mesh. Adult MGs were dissected and the lymph nodes removed. Tissues were briefly washed in HBSS, and chopped into 1 mm 3 pieces. Chopped tissues were digested in HBSS + 300 U ml −1 collagenase (Sigma cat. no. C0130) + 300 μ g ml −1 hyaluronidase (Sigma cat. no. 4272) for 2 h at 37 °C under agitation. Physical dissociation using a P1000 pipette was done every 15 min throughout the enzymatic digestion. EDTA 5 mM was added for 5 min, followed by 0.25% trypsin-EGTA for 1 min, before filtration through a 70 μ m mesh, and two successive washes in 2% FBS/PBS. Cell labelling, flow cytometry and sorting. Samples were incubated in 250 µ l of 2% FBS/PBS with fluorochrome-conjugated primary antibodies for 30 min, with shaking every 10 min. Primary antibodies were washed with 2% FBS/PBS, and cells were resuspended in 2.5 mg ml −1 DAPI (Invitrogen D1306) before analysis. The following primary antibodies were used: APC-conjugated anti-CD45 (1:100, clone 30-F11, eBiosciences), APC-conjugated anti-CD31 (1:100, clone 390, eBiosciences), APC-conjugated anti-CD140a (1:100, clone APA5, eBiosciences) and PE-conjugated anti-CD49f (1:200, clone GoH3, eBiosciences) for embryos; PECy7-conjugated anti-CD24 (1:100, clone M1/69, BD Biosciences), APCconjugated anti-CD29 (1:100, clone eBioHMb1-1, eBiosciences), PE-conjugated anti-CD45 (1:100, clone 30-F11, eBiosciences), PE-conjugated anti-CD31 (1:100, clone MEC 13.33, BD Biosciences), PE-conjugated anti-CD140a (1:100, clone APA5, eBiosciences) for adult MGs. Data analysis and cell sorting were performed on a FACSAria sorter using FACS DiVa software (BD Biosciences). Dead cells were excluded with DAPI; CD45 + , CD31 + and CD140a + cells were excluded (Lin + ) before analysis of the GFP + cells.
Microarray processing and analysis. Sorted CD49f Hi Lgr5-GFP Hi cells (2,000 cells per sample, n = 3 biological replicates) were collected directly in 45 µ l of lysis buffer (20 mM dithiothreitol (DTT), 10 mM Tris-HCl pH 7.4, 0.5% SDS, 0.5 mg ml −1 proteinase K). Samples were then lysed at 65 °C for 15 min and frozen. RNA isolation, amplification and microarray were performed in the Functional Genomics Core, Barcelona. cDNA synthesis, library preparation and amplification were performed as described in ref. 59 . Microarrays were then performed on the Mouse Genome 430 PM strip Affymetrix array at IRB Functional Genomics Core (Barcelona). All results were normalized using the RMA normalization algorithm using the R-bioconductor affy package with standard parameters 60, 61 . Cross experiment normalization was further performed to eliminate the batch effect using non-parametric empirical Bayes frameworks for adjusting data implemented in the ComBat function of the Surrogate Variable Analysis package (SVA) in R-bioconductor 62 . The transcriptional profiles of Lgr5 cells were normalized with the transcriptional profiles of adult BCs arising from K5CreER/Rosa-YFP mice and LCs arising from adult K8CreER/Rosa-YFP (n = 2 for each sample, previously described in ref. 17 ). Only probes upregulated or downregulated by at 1 nature research | reporting summary A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
The confocal imaging data-sets generated were merged and displayed with the ZEN 2 software.
Flow cytometry data analysis and cell sorting was performed on a FACSAria sorter using the FACS DiVa software (BD Biosciences).
Data analysis
The confocal imaging data-sets generated were analysed with the ZEN 2 software.
Flow cytometry data analysis was performed on a FACSAria sorter using the FACS DiVa software (BD Biosciences).
All microarray results were normalized using the RMA normalization algorithm using R-bioconductor affy package with standard parameters. Cross experiment normalization was further performed to eliminate the batch effect using non-parametric empirical Bayes frameworks for adjusting data implemented in ComBat function of the Surrogate Variable Analysis package (SVA) in R-bioconductor. Venn diagrams were generated using Venny 2.0. GSEA analysis was performed using ranked fold change of probe expression values between Lgr5 and BCs or LCs and genes upregulated in LCs or BCs for the displayed dataset. Genes up-regulated in each subset of the Venn Diagrams were tested for enrichment in each Gene Ontology class using the DAVID web server. Sequencing reads were trimmed for adapter sequences using cutadapt (version 1.13) and reads were aligned to the GRCm38 reference genome including ERCC sequences using STAR with default parameters (version 2.5.2b)79. The expression count matrix was generated using HTSeq (version 0.6.0)80 on GENCODE M12 transcript annotations and counts for each protein coding gene were collapsed. Quality control was performed using the scater R package (version 1.2.0)81. Cells that complied with one of the following conditions were excluded: had fewer than 105 counts, showed expression of fewer than 2000 unique genes, had more than 20% counts belonging to
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ERCC sequences, had more than 8% counts belonging to mitochondrial sequences. BCs and EMPs that showed no expression of neither K5 nor K14, and LCs that did not express K8 were further excluded. Out of the 377 samples which passed sequencing, 281 passed quality control. Genes for which less than 20 counts were observed across the complete dataset were excluded from further analysis. Read counts were normalized using scran with default parameters (version 1.2.2) 82. Clustering using the SC3 R package (version 1.3.18)49 and PCA was performed using the prcomp function in R, plots were generated using the ggplot2 R package (version 2.2.1). We chose k=4 (all cells), k=2 (for EMP-only and LC vs BC clustering) for SC3 as this best represented the heterogeneity in our dataset and recapitulated the studied cell lineages. For cluster marker gene discovery we set the thresholds to all genes with an AUC higher than 0.8 and p-value lower than 0.01. Heatmaps were generated using a modified version of the gplots R package (3.0.1). Cell-cycle phase was automatically assigned using the scran package.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability Microarray, RNAseq and single cell RNA sequencing data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession code GSE109711. Previously published microarray data that were re-analysed here are available under accession code GSE69290. Source data for Figure 1d , 1l, 1q, 6d and 7c have been provided as Supplementary Table 1 .
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Life sciences
Study design
All studies must disclose on these points even when the disclosure is negative.
Sample size
No statistical methods were used to predetermine sample size. All experiments were repeated at least three times with similar results, except for microarray and RNAseq for which experiments were repeated twice.
Data exclusions For the single cell RNA sequencing, after initial quality control 24 samples were discarded with cDNA yields of less than 21ng. These samples were replaced with 24 cells from another 384 well plate from the same cell sort by plate reformatting with an acoustic dispenser (LabCyte Echo 525). Cells coming from a row F of the 384-well plate which showed systematic mixing of LC and BC markers were excluded from further analysis due to a likely pipetting error. Out of the 377 samples which passed sequencing, 221 passed quality control. Genes for which less than 20 counts were observed across the complete dataset were excluded from further analysis.
Replication
All attempts at replication were successfull and are shown, n is described in legends.
Randomization The experiments were not randomized. Transgenic mice of mixed background were used and compared to control mice of mixed background.
Blinding
The investigators were not blinded to allocation during experiments and outcome assessment. Blinding was not possible as the same investigator processed the animals and analysed the data.
